Events in the cardiac arrhythmia suppression trial (CAST): Mortality in the entire population enrolled

Journal of the American College of Cardiology

Volumn 18, Issue 1, 1991, Pages 14-19

  Reynolds Haertle, Robin A ^e   Hallstrom, Alfred P ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ENCAINIDE; FLECAINIDE; MORACIZINE;

ADULT; AGED; ARTICLE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0025735814     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(10)80210-4     Document Type: Article

References (19)

1. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
2. Prognostic importance of premature beats following myocardial infarction: experience in the Coronary Drug Project
3. The prognostic importance of premature ventricular complexes in the late post-infarction period: experience in the Coronary Drug Project
4. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction
5. Ventricular premature complexes and sudden death after myocardial infarction
6. Risk stratification and survival after myocardial infarction
7. Effect of propranolol on ventricular arrhythmia: the Beta-Blocker Heart Attack Trial experience
8. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction
9. Ventricular arrhythmias during the first year after acute myocardial infarction: influence of long-term treatment with metoprolol
10. Risk factors for sudden death after acute myocardial infarction: two-year follow-up
11. International Mexiletine and Placebo Antiarrhythmic Coronary Trial: I. Report on arrhythmia and other findings
12. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia
13. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction
14. Cardiac Arrhythmia Suppression Trial [letter]
15. Prognosis of ventricular arrhythmias in relation to sudden cardiac death: therapeutic implications
16. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings
17. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction
18. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty
19. Influence of fibrinolysis and percutaneous transluminal coronary angioplasty on the frequency of ventricular premature complexes